β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 16 β 19 FEBRUARY 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Bisoprolol Actavis
Bisoprolol fumarate 10mg
Tablet
Actavis New Zealand Limited
Niche Generics Limited, Dublin, Ireland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Hizentra
Normal immunoglobulin 200mg/mL
Solution for injection
CSL Behring (NZ) Limited
CSL Behring AG, Bern, Switzerland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Incruse Ellipta
Umeclidinium bromide 74.2mcg equivalent to umeclidinium 62.5mcg
Powder for inhalation
GlaxoSmithKline (NZ) Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Hertfordshire, United Kingdom
Dated this 13th day of February 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go898
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Hemorraid
Hamamelis virginiana 50%w/w
Skin wash impregnated pad
Global Pacific Pharmaceuticals
Diamond Wipes International Inc., California, United States of America
Dated this 13th day of February 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go899
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Pitressin
Vasopressin 20pressor units/mL
Solution for injection
Link Pharmaceuticals Limited
JHP Pharmaceuticals LLC, Michigan, United States of America
Dated this 13th day of February 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go900
65
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare13 February 2015
Medicines, Distribution, Bisoprolol Actavis, Hizentra, Incruse Ellipta, Medicines Act 1981
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare13 February 2015
Medicines, Distribution, Hemorraid, Medicines Act 1981
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare13 February 2015
Medicines, Distribution, Pitressin, Medicines Act 1981
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 16